Generics - Generics

Filter

Current filters:

Generics

Popular Filters

1 to 25 of 1160 results

US FDA approves first generic of AstraZeneca’s Nexium

US FDA approves first generic of AstraZeneca’s Nexium

27-01-2015

The US Food and Drug Administration yesterday approved a generic version of Nexium (esomeprazole), Anglo-Swedish…

AstraZenecaGastro-intestinalsGenericsNexiumRegulationTeva Pharmaceutcal IndustriesUSA

Actavis to acquire UK generics firm Auden Mckenzie

26-01-2015

Ireland-headquartered generic major Actavis said today that it has reached agreement to acquire UK-based…

ActavisAuden MckenzieGenericsMergers & AcquisitionsUK

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

26-01-2015

US biotech major Gilead Sciences has expanded its hepatitis C generic licensing agreements to include…

Anti-viralsBiotechnologyGenericsGilead SciencesIndiaLicensingSovaldiUSA

Growing number of pharmacies operating in Central Europe but market conditions difficult

26-01-2015

Central European area has around 34,200 pharmacy outlets (the number includes pharmacies and pharmacy…

Eastern EuropeGenericsMarkets & MarketingPharmaceuticalPolandPricingRegulationSlovakia

Supernus sues TWi for infringement of Oxtellar XR patents

22-01-2015

US drugmaker Supernus Pharmaceuticals says that it has sued generic drug makers Taiwan-based TWi Pharmaceuticals…

GenericsLegalNeurologicalOxtellar XRPatentsSupernus PharmaceuticalsTWi PharmaceuticalsUSA

New phase of MAb biosimilars opportunities in Japan

New phase of MAb biosimilars opportunities in Japan

21-01-2015

The launch of Remicade (infliximab, from Johnson & Johnson) biosimilar in December 2014 in the Japan…

BiosimilarserythropoietinGenericsJapanMarkets & MarketingRegulationRemicade

Strides Arcolab to make and distribute Gilead’s TAF

20-01-2015

Indian drugmaker Strides Arcolab Limited has entered into a licensing agreement with US biotech major…

Anti-viralsGenericsGilead SciencesLicensingProductionStrides Arcolabtenofovir alafenamide

EMA to boost international cooperation on generics

EMA to boost international cooperation on generics

19-01-2015

The European Medicines Agency is ready to share its assessments of applications for generic medicines…

EuropeGenericsGlobalRegulation

Supernus sues Par for Trokendi XR patents infringement

19-01-2015

US drugmaker Supernus Pharmaceuticals says it has sued privately-held generics firm Par Pharmaceutical…

GenericsLegalNeurologicalPar PharmaceuticalsPatentsSupernus PharmaceuticalsTrokendi XRUSA

Akorn files ANDA for generic Durezol

16-01-2015

US generic drugmaker Akorn has confirmed that it has filed an Abbreviated New Drug Application (ANDA)…

AkornAlconDurezolGenericsNovartisOphthalmicsPatentsRegulationUSA

Hikma to launch colchicine in USA as Takeda’s injunction fails

13-01-2015

Jordon-headquartered Hikma Pharmaceuticals saw its shares rise 4.2% to a record high of £23.80, after…

Anti-Arthritics/RheumaticsColchicineColcrysGenericsHikma PharmaceuticalsLegalMarkets & MarketingMitigareTakeda PharmaceuticalUSA

AMRI to develop parenteral drug products with Genovi

13-01-2015

Albany Molecular Research has entered into several development and supply agreements with the UK’s…

Albany Molecular ResearchEuropeGenericsGenovi PharmaceuticalsMarkets & MarketingProductionUSA

Helsinn settles with Sandoz over Aloxi in USA

12-01-2015

Privately-held Swiss cancer specialist Helsinn Group say it has entered into a settlement agreement with…

AloxiEisaiGenericsHelsinn GroupLegalNovartisOncologyPatentsSandozUSA

Health Canada instigates quarantine of products from Sri Krishna Pharmaceuticals

Health Canada instigates quarantine of products from Sri Krishna Pharmaceuticals

07-01-2015

At Health Canada's request, Canadian importers have agreed to quarantine health products made with active…

CanadaGenericsIndiaItalyRegulationSri Krishna Pharmaceuticals

Russian government takes steps to prevent further drug price increases

Russian government takes steps to prevent further drug price increases

05-01-2015

The Russian government is designing a number of measures aimed at preventing a further increase of drug…

GenericsPricingRussia

Leading Russian drugmakers suspend production of cheap drugs

Leading Russian drugmakers suspend production of cheap drugs

24-12-2014

Some 16 leading Russian pharmaceutical companies have officially announced suspension of the production…

GenericsKalashnikovPricingProductionRussia

FTC reports 2013 patent dispute settlements, with 29 potential pay-for-delay deals

FTC reports 2013 patent dispute settlements, with 29 potential pay-for-delay deals

23-12-2014

In fiscal year 2013, companies filed a total of 145 final patent dispute settlements, of which 29 created…

GenericsLegalUSA

New Indian moves on pharma pricing

New Indian moves on pharma pricing

22-12-2014

Early January 2015, the Indian government is to come out with a new list of life saving drugs whose prices…

GenericsPoliticsPricing

UCB, Advent and Avista Capital terminate $1.5 billion divestment agreement

UCB, Advent and Avista Capital terminate $1.5 billion divestment agreement

17-12-2014

Belgian drugmaker UCB and private equity firms Avista Capital and Advent International have mutually…

BelgiumBusiness FinanceConcertaGenericsUCB

With buy of Veropharm, Abbott to significantly increase revenue in Russia

With buy of Veropharm, Abbott to significantly increase revenue in Russia

17-12-2014

US drugmaker Abbott plans to significantly increase its revenue in the Russian market over the next several…

AbbottFinancialGenericsMarkets & MarketingProductionRussiaVeropharm

Ranbaxy may establish production in Russia

Ranbaxy may establish production in Russia

16-12-2014

Generic pharma company Ranbaxy, one of India’s largest drugmakers which is in the process of being…

Antibiotics and Infectious diseasesGenericsNeurologicalProductionRanbaxyRussia

Actavis files emergency appeal against District Court decision on Namenda

Actavis files emergency appeal against District Court decision on Namenda

16-12-2014

Ireland-headquartered generics major Actavis is filing an emergency appeal to the US Court of Appeals…

ActavisGenericsLegalNamendaNeurologicalUSA

1 to 25 of 1160 results

Back to top